The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study
出版年份 2022 全文链接
标题
The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study
作者
关键词
-
出版物
Cardiovascular Diabetology
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-04-16
DOI
10.1186/s12933-022-01483-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments
- (2021) Giovanni Targher et al. Nature Reviews Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk
- (2021) Emir Muzurović et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The association of hepatic steatosis and fibrosis with heart failure and mortality
- (2021) Jiyun Park et al. Cardiovascular Diabetology
- Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study
- (2020) Jun Hyung Kim et al. Cardiovascular Diabetology
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
- (2020) Hyeok-Hee Lee et al. Cardiovascular Diabetology
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients
- (2019) Aino Latva-Rasku et al. DIABETES CARE
- Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study
- (2019) Mee Kyoung Kim et al. Cardiovascular Diabetology
- Visit-to-visit variability of metabolic parameters and risk of heart failure: A nationwide population-based study
- (2019) Soonil Kwon et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Risk of early mortality and cardiovascular disease in type 1 diabetes: a comparison with type 2 diabetes, a nationwide study
- (2019) You-Bin Lee et al. Cardiovascular Diabetology
- Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study
- (2019) Francesco Baratta et al. Clinical Gastroenterology and Hepatology
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease
- (2018) Yao-Yao Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Association between abdominal obesity and increased risk for the development of hypertension regardless of physical activity: A nationwide population-based study
- (2018) Eun-Jung Rhee et al. Journal of Clinical Hypertension
- Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study
- (2017) Mee Kyoung Kim et al. EUROPEAN HEART JOURNAL
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- Association between alcohol consumption pattern and the incidence risk of type 2 diabetes in Korean men: A 12-years follow-up study
- (2017) Dae-Yeon Lee et al. Scientific Reports
- Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study
- (2017) Hye Young Lee et al. Scientific Reports
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and diabetes
- (2016) Jonathan M. Hazlehurst et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
- (2013) Raluca Pais et al. JOURNAL OF HEPATOLOGY
- Validation of fatty liver index and lipid accumulation product for predicting fatty liver in Korean population
- (2011) Jeong H. Kim et al. LIVER INTERNATIONAL
- Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease
- (2010) Gabriela Ruffillo et al. JOURNAL OF HEPATOLOGY
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search